Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination probiotic biologic consisting of heat-attenuated strains of *Lactobacillus fermentum* and *Lactobacillus paracasei*. [1] It is used to treat allergic disorders such as atopic dermatitis, allergic asthma, and allergic rhinitis. [1] The mechanism of action involves modulating the immune system's response to allergens. [1] It targets specific regions in the intestine, like Peyer's patches, regulates the production of inflammatory cytokines, and supports a healthy balance of gut microflora. [1] Clinical studies in children have demonstrated that this combination can reduce the severity of atopic dermatitis and asthma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactobacillus fermentum + lactobacillus paracasei.